TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth Tilt how tags are computed

Q2 2024 · 127 positions · Total reported value $937.87M · Top-10 concentration 36.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 127 equity positions with a combined reported value of $937.87M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt.

The largest disclosed positions as of Q2 2024 were TARS ($61.29M), EOLS ($52.59M), KALV ($49.70M). By sector, the heaviest allocations are Health Care 76.8%, Technology 2.2%. Versus the prior quarter, allocation shifted toward Technology (+0.8pp), Real Estate (+0.7pp) and away from Health Care (-0.8pp), Other (-0.9pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q2 2024 were DVAX ($28.07M), JAZZ ($14.94M), TDOC ($9.78M).

Of the 1 positions fully exited versus the prior quarter, the largest were MOR ($14.52M), DCPH ($9.44M), NTLA ($5.50M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • DVAX DYNAVAX TECHNOLOGIES CORP · $28.07M
  • JAZZ JAZZ PHARMACEUTICALS PLC · $14.94M
  • TDOC TELADOC HEALTH INC · $9.78M
  • BIIB BIOGEN INC · $8.11M
  • REPL REPLIMUNE GROUP INC · $7.25M
  • INSM INSMED INC · $6.70M
  • BEAM BEAM THERAPEUTICS INC · $6.33M
  • MRUS MERUS N V · $5.92M

Fully Exited (vs previous quarter)

  • MOR MORPHOSYS AG · prev qtr: $14.52M
  • DCPH DECIPHERA PHARMACEUTICALS IN · prev qtr: $9.44M
  • NTLA INTELLIA THERAPEUTICS INC · prev qtr: $5.50M
  • BLUE BLUEBIRD BIO INC · prev qtr: $3.20M
  • EQC EQUITY COMWLTH · prev qtr: $3.12M
  • MNMD MIND MEDICINE MINDMED INC · prev qtr: $2.82M
  • KNTE KINNATE BIOPHARMA INC · prev qtr: $2.60M
  • AMRN AMARIN CORP PLC · prev qtr: $2.23M

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.8%
Technology 2.2%
Materials 0.4%
Financials 0.1%
Other 19.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.25M $61.29M 6.54%
6.54%
Hold
2 4.85M $52.59M 5.61%
5.61%
Add
3 4.22M $49.70M 5.30%
5.30%
Add
4 1.33M $33.35M 3.56%
3.56%
Hold
5 450.00K $28.66M 3.06%
3.06%
Add
6 2.50M $28.07M 2.99%
2.99%
New
7 27.00K $24.45M 2.61%
2.61%
Hold
8 1.50M $24.38M 2.60%
2.60%
Add
9 300.00K $22.65M 2.42%
2.42%
Hold
10 700.00K $21.41M 2.28%
2.28%
Hold
11 300.00K $20.55M 2.19%
2.19%
Add
12 2.75M $18.29M 1.95%
1.95%
Hold
13 1.39M $18.12M 1.93%
1.93%
Add
14 1.23M $17.29M 1.84%
1.84%
Add
15 316.50K $17.09M 1.82%
1.82%
Add
16 750.00K $16.15M 1.72%
1.72%
Add
17 921.14K $16.06M 1.71%
1.71%
Add
18 2.78M $15.87M 1.69%
1.69%
Add
19 400.00K $15.40M 1.64%
1.64%
Add
20 140.00K $14.94M 1.59%
1.59%
New
21 4.48M $14.82M 1.58%
1.58%
Add
22 115.02K $14.21M 1.51%
1.51%
Add
23 405.60K $13.75M 1.47%
1.47%
Hold
24 747.62K $12.93M 1.38%
1.38%
Add
25 2.15M $12.17M 1.30%
1.30%
Add
26 1.62M $11.95M 1.27%
1.27%
Hold
27 150.00K $11.70M 1.25%
1.25%
Hold
28 625.31K $11.67M 1.25%
1.25%
Add
29 3.75M $10.96M 1.17%
1.17%
Add
30 2.33M $10.88M 1.16%
1.16%
Add
31 8.22M $9.94M 1.06%
1.06%
Add
32 1.00M $9.78M 1.04%
1.04%
New
33 7.79M $9.51M 1.01%
1.01%
Add
34 572.70K $9.40M 1.00%
1.00%
Add
35 1.10M $9.36M 1.00%
1.00%
Hold
36 720.00K $8.71M 0.93%
0.93%
Hold
37 281.20K $8.48M 0.91%
0.91%
Hold
38 3.06M $8.26M 0.88%
0.88%
Hold
39 35.00K $8.11M 0.86%
0.86%
New
40 1.60M $7.47M 0.80%
0.80%
Hold
41 805.44K $7.25M 0.77%
0.77%
New
42 3.10M $7.16M 0.76%
0.76%
Hold
43 150.00K $7.15M 0.76%
0.76%
Hold
44 264.69K $6.85M 0.73%
0.73%
Hold
45 100.00K $6.70M 0.71%
0.71%
New
46 1.85M $6.47M 0.69%
0.69%
Hold
47 120.00K $6.36M 0.68%
0.68%
Add
48 270.00K $6.33M 0.68%
0.68%
New
49 623.33K $6.07M 0.65%
0.65%
Add
50 100.00K $5.92M 0.63%
0.63%
New

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, TANG CAPITAL MANAGEMENT LLC reported 127 equity positions worth $937.87M in aggregate; its largest disclosed positions were TARS ($61.29M), EOLS ($52.59M), KALV ($49.70M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $937.87M of long equity holdings across 127 positions as of 2024-Q2. Top-10 holdings account for 36.9% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →